Partnering with Biotechs
to Scale Smarter from
Seed to Success
Unlock the Full Potential of Your Biotech
With decades of experience across the Life Sciences industry with a focus on biotech development, capital strategy, and clinical development execution, Deb Kientop partners with biotechs to navigate their growth journey with precision, from initial funding through commercialization and exit.
At the head of GLSA Biotech, Deb delivers tailored strategies that integrate scientific innovation, capital efficiency, and operational execution to drive sustainable growth, strategic alignment, and long-term value for biotech companies and their investors.
Deb brings a hands-on, tailored approach to clinical development strategy, identifying cost-saving opportunities without compromising speed or quality empowering biotechs to achieve key milestones with greater efficiency and reduced financial risk.
Deb Kientop, MBA, BCPA
Global Biotech Strategy Executive
GLSA Biotech Solutions
How Deb Supports Biotechs
Tailored Capital Strategy
Align fundraising with development goals
Clinical Development Optimization
Strategic planning to reduce cost, risk, and time
Integrated Growth Planning
Science, business, and investor strategy in sync
Investor & Partner Introductions
Leverage GLSA’s trusted global network
Commercial Readiness
Prepare for scale, market fit, and investor milestones
Who Should Connect with Deb
Biotechs seeking funding, clinical strategy, or operational support
Investors & Strategic Partners scouting for high-potential biotech assets
CROs, CMOs & CDMOs looking to align with biotech innovators
Accelerators & Incubators needing expert support for portfolio companies
GLSA Clinical Development
Fit-for-purpose development plans tailored to Biotech size and stage
Streamlined study designs and operational models
Vendor and Site Selection strategies that minimize budget waste
Global Recruitment and execution solutions to reduce delays